CFO
CORZ icon

Custos Family Office’s Core Scientific CORZ Stock Holding History

Custos Family Office’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.77M Hold
121,306
– – 1.21% 16
2025
Q3 		$2.18M Hold
121,306
– – 1.23% 16
2025
Q2 		$2.07M Hold
121,306
– – 0.66% 25
2025
Q1 		$878K Buy
121,306
+69,060
+132% +$786K 0.31% 34
2024
Q4 		$734K Hold
52,246
– – 0.26% 37
2024
Q3 		$620K Hold
52,246
– – 0.22% 37
2024
Q2 		$486K Buy
+52,246
New +$267K 0.19% 40

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return

Custos Family Office's CORZ Position: Q4 2025 in Review

Custos Family Office held its Core Scientific (CORZ) position steady in Q4 2025 at 121,306 shares worth $1.77M. The position accounts for 1.21% of the portfolio, ranked #16.

Custos Family Office first reported a position in CORZ in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.18M in Q3 2025. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

  • Custos Family Office held 121,306 shares of Core Scientific worth $1.77M as of Q4 2025.
  • Custos Family Office left its Core Scientific share count unchanged in Q4 2025.
  • Core Scientific made up 1.21% of Custos Family Office's portfolio in Q4 2025, its #16 holding.
  • Custos Family Office first reported a position in Core Scientific in Q2 2024 and has held it in 7 quarters since.
  • Custos Family Office's Core Scientific position peaked at $2.18M in Q3 2025.
  • 367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on Custos Family Office's 13F filing for Q4 2025, filed 17 Feb 2026.